Worldwide Healthcare Trust PLC Edison issues update on Worldwide Healthcare Trust
23 November 2016 - 11:05PM
RNS Non-Regulatory
TIDMWWH
Worldwide Healthcare Trust PLC
23 November 2016
London, UK, 23 November 2016
Edison issues update on Worldwide Healthcare Trust (WWH)
Worldwide Healthcare Trust (WWH) aims to generate long-term
capital growth from investing in a portfolio of global healthcare
stocks; a differentiating feature is the trust's c 15% exposure to
emerging markets. Following a change in mandate in 2010, WWH now
invests in all sectors of the healthcare industry. Performance
versus its benchmarks is particularly strong over three, five and
10 years. Sam Isaly has been lead manager since launch in 1995; he
is co-founder of the world's largest specialist healthcare
investment company, OrbiMed Capital.
Following the recent US election with a win for Trump rather
than Clinton, who was very vocal on drug pricing, WWH's share price
has rallied (more strongly than the US healthcare sector). The
current discount to cum-income NAV of 1.9% compares to a range of a
0.7% premium to a 13.0% discount over the last 12 months (average
of 6.2%). It is also narrower than the average discounts of the
last three, five and 10 years (range of 4.8% to 6.5%). Given WWH's
focus on capital growth rather than income, it has a modest
dividend yield, currently 0.8%.
Click here to view the full report
All reports published by Edison are available to download free
of charge from its website: www.edisoninvestmentresearch.com
About Edison: Edison is an international equity research firm
with a team of over 70 analysts, investment and roadshow
professionals and works with both large and smaller capitalised
companies, blue chip institutional investors, wealth managers,
private equity and corporate finance houses to support their
capital markets activity. Edison provides services to more than 420
retained corporate and investor clients from offices in London, New
York, Frankfurt, Sydney and Wellington. Edison is authorised and
regulated by the Financial Conduct Authority.
Edison is not an adviser or broker-dealer and does not provide
investment advice. Edison's reports are not solicitations to buy or
sell any securities.
Contact details: Learn more at www.edisongroup.com and connect
with Edison on:
LinkedIn www.linkedin.com/company/edison-investment-research
--------- ----------------------------------------------------
Twitter www.twitter.com/Edison_Inv_Res
--------- ----------------------------------------------------
YouTube www.youtube.com/edisonitv
--------- ----------------------------------------------------
Google+ https://plus.google.com/105425025202328783163/posts
--------- ----------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRABJBTTMBMTBBF
(END) Dow Jones Newswires
November 23, 2016 07:05 ET (12:05 GMT)
Finsbury Worldwide Pharm (LSE:FWP)
Historical Stock Chart
From Oct 2024 to Nov 2024
Finsbury Worldwide Pharm (LSE:FWP)
Historical Stock Chart
From Nov 2023 to Nov 2024